Press

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras vel sagittis libero, a lacinia nisi. Interdum et malesuada fames ac ante ipsum primis in faucibus. Donec nec nisl turpis. Pellentesque pretium pellentesque maximus. Nam efficitur massa justo, eget laoreet odio congue convallis. Proin sagittis mauris sit amet justo cursus, sit amet porta eros eleifend. Nullam felis tortor, pharetra a consequat eget, luctus non massa. Cras sed efficitur felis, sollicitudin gravida eros. Mauris congue efficitur tempor.

Renseigner une description via Articles > Categories > Press > Champ 'Description' pour remplacer ce Lorem ipsum.

Finding the one: How to choose a Clinical Partner in Sea of Service Providers

Press
Press room

What should companies look for when selecting a CRO clinicalpartner?  Just one in ten drug candidates are successful in clinical trials, and the number of products making it from development to approval is currently at an all-time low.It means sponsors […]

Read more

Integration of Biomarker Validation in Clinical Development in Oncology

Press

The development and qualification of biomarkers are keys to the future of drug development and precision medicine, particularly in oncology. Read IDDI Article published in Applied Clinical Trials.  Precision medicine relies on validated biomarkers that allow classification of patients by […]

Read more

IDDI in Contract Pharma

Press
Press room

Insight on the pharma and biopharma trends impacting CROs, Outsourcing in today’s market, and advances in clinical research. READ IDDI ARTICLE PUBLISHED IN CONTRACT PHARMA ! Kristin Brooks, Contract Pharma 04.27.20 Serge Bodart of IDDI provides insight on the pharma […]

Read more

IDDI: coup de pouce à la médecine personnalisée

Press

IDDI: coup de pouce à la médecine personnalisée L’entreprise de Louvain-la-Neuve développe une méthode statistique innovante, qui pourrait bousculer les essais cliniques. CHRISTOPHE DE CAEVEL Trends Tendances P20 Feb.21, 2019 Vous trouvez que les projets de recherche conduisent trop rarement […]

Read more

Personalized Medicine: Getting More Out of Clinical Trials

February 15, 2019

Press

IDDI in Contract Pharma Magazine IDDI, BMS Consortium aims to establish that the GPC statistical method can complement the design, analysis and interpretation of clinical trial results; Kristin Brooks, Contract Pharma 02.15.19 Results of randomized clinical trials can be somewhat limited. […]

Read more